Pioglitazone (Pioglu M 15) is a thiazolidinedione antidiabetic, prescribed for type 2 diabetes in certain patients. It is used along with diet and exercise. It may be used alone or with other ...

Please provide your email address to receive an email when new articles are posted on . Both 15 mg and 30 mg pioglitazone doses have similar efficacy as 45 mg for preventing new-onset diabetes, stroke ...

San Diego, CA, June 11, 2005 - A new study presented today at the American Diabetes Association (ADA) 65th Annual Scientific Sessions showed that the type 2 diabetes drug ACTOS reduced C-reactive ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Pioglitazone (Piolem ) is a thiazolidinedione ...

Launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg) + Pioglitazone (15 mg) + Metformin (500mg/1000mg) in a sustained release (SR) formulation. This offers patients with type ...

The diabetes drug pioglitazone is unlikely to modify progression in early Parkinson's disease (PD), new results from a phase 2 study suggest. The authors, the NINDS Exploratory Trials in Parkinson ...

Macleods Pharmaceuticals has recalled 31,968 bottles of pioglitazone hydrochloride in the US market after the tablets were found to be ‘superpotent’, according to an enforcement report by the US Food ...

A recent Delhi High Court directive restoring a ban on two diabetes fixed dose combination (FDC) drugs has put the spotlight back on FDCs, and pioglitazone – a drug with a troubled legacy, say doctors ...

Mylan Pharmaceuticals Inc., a subsidiary of Mylan Inc. (MYL), recently announced that it has launched its generic versions of Takeda Pharmaceutical Co. Ltd.’s (TKPYY) diabetes drugs, Actos ...

Glenmark Pharmaceuticals has launched a fixed dose combination which aims to improve glycemic control among adults with insulin resistance, for those whose diabetes is not controlled by metformin, and ...